Alemtuzumab (sold as Lemtrada or previously Campath) is a monoclonal antibody medication given by intravenous infusion. It targets the CD52 protein on white blood cells to treat relapsing forms of multiple sclerosis and chronic lymphocytic leukemia
Alemtuzumab (sold as Lemtrada or previously Campath) is a monoclonal antibody medication given by intravenous infusion. It targets the CD52 protein on white blood cells to treat relapsing forms of multiple sclerosis and chronic lymphocytic leukemia
Image 1 of 1